Cargando…

Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia

PURPOSE: To evaluate the effects of body weight loss on reproductive outcomes in young women with early-stage endometrial cancer (EC) and atypical hyperplasia (AH) who underwent fertility-sparing therapy. PATIENTS AND METHODS: Patients with well-differentiated EC (n=8, FIGO stage Ia) and AH (n=36) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanfang, Li, Dan, Yan, Qi, Song, Xueru, Tian, Wenyan, Wang, Yingmei, Teng, Fei, Wei, Likun, Wang, Jinghua, Zhang, Huiying, Xue, Fengxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286730/
https://www.ncbi.nlm.nih.gov/pubmed/34285588
http://dx.doi.org/10.2147/CMAR.S316040
_version_ 1783723774224367616
author Zhang, Yanfang
Li, Dan
Yan, Qi
Song, Xueru
Tian, Wenyan
Wang, Yingmei
Teng, Fei
Wei, Likun
Wang, Jinghua
Zhang, Huiying
Xue, Fengxia
author_facet Zhang, Yanfang
Li, Dan
Yan, Qi
Song, Xueru
Tian, Wenyan
Wang, Yingmei
Teng, Fei
Wei, Likun
Wang, Jinghua
Zhang, Huiying
Xue, Fengxia
author_sort Zhang, Yanfang
collection PubMed
description PURPOSE: To evaluate the effects of body weight loss on reproductive outcomes in young women with early-stage endometrial cancer (EC) and atypical hyperplasia (AH) who underwent fertility-sparing therapy. PATIENTS AND METHODS: Patients with well-differentiated EC (n=8, FIGO stage Ia) and AH (n=36) who achieved complete regression after fertility-sparing therapy were retrospectively reviewed. Patients were divided into a weight loss group (n=25) and a non-weight loss group (n=19). Subgroup analysis according to body mass index and relative weight loss were performed to investigate the effect of weight loss on pregnancy and live birth outcomes. Univariate and multivariate logistic regression analyses were undertaken to determine pregnancy-associated factors. RESULTS: Mean body weight and body mass index at pre-progestin treatment and at fertility treatment initiation were 70.63±12.03 and 67.08±8.18 kg, respectively, 27.06±4.44 and 25.73±3.15 kg/m(2), respectively. Twenty-five patients (56.82%) lost weight, the median absolute weight loss was 5.00 kg (1.00–34.50), and the median relative weight loss was 6.70% (1.00–36.00%) over a median of 12 months (5.00–97.00). A favorable pregnancy rate (65.91%) and live birth rate (50.00%) were achieved. The pregnancy and live birth rates were meaningfully higher in the weight loss group than in the non-weight loss group (88.00% vs 36.84%, P=0.000; 64.00% vs 31.58%, P=0.033); weight loss ≥5% significantly increased pregnancy and live birth rate in patients with BMI ≥25 kg/m(2). The risk ratio of weight loss ≥5% in multivariate logistic analysis for pregnancy was 10.448 (1.102, 99.056, P=0.041). CONCLUSION: Weight loss could positively affect pregnancy rate and improve live birth rate in overweight and obese women with early-stage EC and AH during/after fertility-sparing therapy. Weight loss ≥5% increased pregnancy and livebirth rates significantly in overweight and obese women.
format Online
Article
Text
id pubmed-8286730
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82867302021-07-19 Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia Zhang, Yanfang Li, Dan Yan, Qi Song, Xueru Tian, Wenyan Wang, Yingmei Teng, Fei Wei, Likun Wang, Jinghua Zhang, Huiying Xue, Fengxia Cancer Manag Res Original Research PURPOSE: To evaluate the effects of body weight loss on reproductive outcomes in young women with early-stage endometrial cancer (EC) and atypical hyperplasia (AH) who underwent fertility-sparing therapy. PATIENTS AND METHODS: Patients with well-differentiated EC (n=8, FIGO stage Ia) and AH (n=36) who achieved complete regression after fertility-sparing therapy were retrospectively reviewed. Patients were divided into a weight loss group (n=25) and a non-weight loss group (n=19). Subgroup analysis according to body mass index and relative weight loss were performed to investigate the effect of weight loss on pregnancy and live birth outcomes. Univariate and multivariate logistic regression analyses were undertaken to determine pregnancy-associated factors. RESULTS: Mean body weight and body mass index at pre-progestin treatment and at fertility treatment initiation were 70.63±12.03 and 67.08±8.18 kg, respectively, 27.06±4.44 and 25.73±3.15 kg/m(2), respectively. Twenty-five patients (56.82%) lost weight, the median absolute weight loss was 5.00 kg (1.00–34.50), and the median relative weight loss was 6.70% (1.00–36.00%) over a median of 12 months (5.00–97.00). A favorable pregnancy rate (65.91%) and live birth rate (50.00%) were achieved. The pregnancy and live birth rates were meaningfully higher in the weight loss group than in the non-weight loss group (88.00% vs 36.84%, P=0.000; 64.00% vs 31.58%, P=0.033); weight loss ≥5% significantly increased pregnancy and live birth rate in patients with BMI ≥25 kg/m(2). The risk ratio of weight loss ≥5% in multivariate logistic analysis for pregnancy was 10.448 (1.102, 99.056, P=0.041). CONCLUSION: Weight loss could positively affect pregnancy rate and improve live birth rate in overweight and obese women with early-stage EC and AH during/after fertility-sparing therapy. Weight loss ≥5% increased pregnancy and livebirth rates significantly in overweight and obese women. Dove 2021-07-14 /pmc/articles/PMC8286730/ /pubmed/34285588 http://dx.doi.org/10.2147/CMAR.S316040 Text en © 2021 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Yanfang
Li, Dan
Yan, Qi
Song, Xueru
Tian, Wenyan
Wang, Yingmei
Teng, Fei
Wei, Likun
Wang, Jinghua
Zhang, Huiying
Xue, Fengxia
Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia
title Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia
title_full Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia
title_fullStr Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia
title_full_unstemmed Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia
title_short Weight Loss Improves Pregnancy and Livebirth Outcomes in Young Women with Early-Stage Endometrial Cancer and Atypical Hyperplasia
title_sort weight loss improves pregnancy and livebirth outcomes in young women with early-stage endometrial cancer and atypical hyperplasia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286730/
https://www.ncbi.nlm.nih.gov/pubmed/34285588
http://dx.doi.org/10.2147/CMAR.S316040
work_keys_str_mv AT zhangyanfang weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia
AT lidan weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia
AT yanqi weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia
AT songxueru weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia
AT tianwenyan weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia
AT wangyingmei weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia
AT tengfei weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia
AT weilikun weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia
AT wangjinghua weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia
AT zhanghuiying weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia
AT xuefengxia weightlossimprovespregnancyandlivebirthoutcomesinyoungwomenwithearlystageendometrialcancerandatypicalhyperplasia